Inhaled corticosteroid use and bone-mineral density in patients with asthma
Top Cited Papers
- 1 April 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9213) , 1399-1403
- https://doi.org/10.1016/s0140-6736(00)02138-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Morbidity from asthma in relation to regular treatment: a community based studyThorax, 1999
- One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral densityThorax, 1999
- Bone mineral density and body composition in patients with airflow obstruction—the role of inhaled steroid therapy, disease and lifestyleClinical and Experimental Allergy, 1998
- Bone Mineral Density and Bone Turnover in Asthmatics Treated with Long-Term Inhaled or Oral GlucocorticoidsJournal of Bone and Mineral Research, 1998
- Reference ranges of bone mineral density for women in southern England: the impact of local data on the diagnosis of osteoporosisThe British Journal of Radiology, 1996
- Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroidsJournal of Allergy and Clinical Immunology, 1995
- Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthmaJournal of Allergy and Clinical Immunology, 1995
- Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolismJournal of Allergy and Clinical Immunology, 1994
- Asthma and growth.Archives of Disease in Childhood, 1993
- Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids.Thorax, 1992